Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 41.00
Ask: 42.00
Change: -2.00 (-4.60%)
Spread: 1.00 (2.439%)
Open: 43.50
High: 43.50
Low: 41.50
Prev. Close: 43.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Alusid in collaboration with Imerys

30 Jan 2023 07:00

RNS Number : 1646O
Frontier IP Group plc
30 January 2023
 

Reach - a non-regulatory announcement

AIM: FIPP

30 January 2023

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Alusid extends product range in collaboration with global speciality minerals group Imerys

 

Frontier IP, a specialist in commercialising intellectual property, notes the following announcement from portfolio company Alusid (the "Company") that it has successfully collaborated with Imerys, a world leader in specialty minerals to make floor tiles.

 

The collaboration started after Alusid was named as one of two winners in the Imerys Start-Up Innovation Factory competition launched last year, from sixty-five companies from around the world selected to participate. The aim of the competition's first edition was to enable Imerys to research potential partners to collaborate on innovation to meet circular economy challenges.

 

Over the past few months, Alusid and Imerys have run two parallel trials to make products using Imerys by-products: the floor tiles, and another to make larger items such as coffee tables and worktops. Both were successful, and the floor tiles are now attracting commercial interest, including from a leading retailer. Frontier IP holds a 38.9 per cent equity stake in the Company.

 

Imerys generated €4.4 billion in revenues during 2021 and employs 16,300 people.

 

 

Frontier IP Chief Executive Neil Crabb said: "We're delighted with Alusid's success in, first, being one of only two winners from a global competition organised by a multinational group, and second, in developing a wholly new product from Imerys' by-products. Success provides further validation of the Company's unique technology to recycle industrial waste into premium-quality tiles and surfaces."

 

Alusid statement follows:

Alusid extends product range in collaboration with global speciality minerals group Imerys

 

Alusid has successfully produced high-quality, hard-wearing floor tiles made from 100 per cent recycled waste after being named as one of the winners in the Start-Up Innovation Factory competition launched by Imerys, a world leader in minerals-based specialty solutions.

 

The aim of the first edition of the competition, launched last year, was to enable Imerys to research potential partners to collaborate on innovation to meet circular economy challenges on technical themes, such as recovering and recycling construction material waste. Sixty-five start-ups from around the world were selected to participate.

 

Alusid has been trialling tile manufacture using six Imerys by-products over the past few months as a continuation of the competition. An Imerys team, led by Cédric Poilly, Customer Application Engineer for Ceramics EMEA, provided support . Two parallel projects were run: one making the floor tiles and the other larger items, such as coffee tables and worktops. Both proved successful, and the next step is to scale up the technology for industrial production.

 

Made from 100 per cent recycled waste, 90 per cent of which came from Imerys, the tiles use three by-products in the recipe, with scope to include additional materials directly produced by Imerys or from its customers.

 

The tiles have the same performance as those made from non-recycled materials, and have already attracted interest from potential customers, including a leading retail brand.

 

Benefits include the use and recycling of surplus raw materials and by-products that would normally go to waste. Alusid's processes consume less gas to manufacture than conventional tiles with energy usage potentially cut by more than 35 per cent because of lower firing temperatures and the use of dry powder granulation rather than spray drying. Water use is also reduced by up to 75 per cent.

 

Alasdair Bremner, Alusid's CEO said: "Working with Imerys on this project has expanded our available sources of recycled material and allowed us to create a product missing from our range, a hard-wearing, high-quality floor tile. Imerys extensive knowledge and their scale means they have the capacity to help us precise our business model and ultimately reduce the environmental impact of tile production. In the initial pilot trial, we had to deal with some warping and adapting with firing these unconventional materials. However, the results are promising enough for us to envision industrial trials. Our aim is to achieve porcelain stoneware classification on water absorption and breaking strength, making our tiles as good as tiles made from non-recycled materials."

 

Frederic Jouffret, Imerys Vice-President, Performance Minerals Science & Technology, said: "Working with start-ups through this challenge was very educational and promising for Imerys. The challenge itself has created a more structured approach for open innovation in the future."

 

 

Alusid statement ends

 

ENQUIRIES

 

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

T: 0203 328 5656

 

 

 

 

ABOUT IMERYS:

The world leader in mineral-based specialty solutions for industry, with €4.4 billion revenue and 16,300 employees in 2021, Imerys delivers high value-added, functional solutions to diversified set of industrial sectors, from processing industries to consumer goods. The Group draws on its knowledge of applications, technological expertise and its material science know-how to deliver solutions based on beneficiation of its mineral resources, synthetic minerals and formulations. These contribute essential properties to customers' products and performance, including refractoriness, hardness, conductivity, opacity, durability, purity, lightness, filtration, absorption and repellency. Imerys is determined to develop responsibly, in particular by fostering the emergence of environmentally friendly products and processes.

 

ABOUT ALUSID

Alusid creates beautiful, premium-quality tiles and architectural surfaces The company creates beautiful, premium quality tiles and architectural surfaces by recycling industrial waste ceramics, glass and other materials much of which would otherwise end in landfill. Tiles are made from a minimum of 95 per cent recycled content and usually contain more.

 

The company's Sequel ranges are distributed exclusively by Parkside Architectural Tiles, the commercial arm of Topps Tiles. Sequel Vibe was named Wall Tile of The Year in The Tile Association's prestigious in 2020.

 

Alusid also makes its own products under the brand name SilicaStone distributed in the UK by Panaz. Customers include COS, part of H&M, Christian Dior, Nando's, Harrods, Selfridges, Amazon UK and Pret-a-Manger.

 

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRANKOBDOBKDCDB
Date   Source Headline
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project
30th Nov 20225:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.